Overview
LRMR market data
Price History
LRMR price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for LRMR. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
HC Wainwright & Co. Assumes Larimar Therapeutics at Buy, Announces Price Target of $10Benzinga · Jul 2, 2026, 11:00 AM
Baird Maintains Outperform on Larimar Therapeutics, Lowers Price Target to $5Benzinga · Jun 30, 2026, 11:50 AM
Larimar Stock Slides 15% Despite FDA Backing Rolling Submission For Rare Disease DrugBenzinga · Jun 29, 2026, 2:20 PM
Biohaven, Goodyear Tire And Other Big Stocks Moving Lower In Monday’s Pre-Market SessionBenzinga · Jun 29, 2026, 12:15 PM
Why Universe Pharmaceuticals Shares Are Trading Higher By Around 228%; Here Are 20 Stocks Moving PremarketBenzinga · Jun 29, 2026, 11:05 AM
8-K filing — Larimar Therapeutics, Inc. (LRMR)SEC EDGAR · Jun 29, 2026, 10:33 AM
JP Morgan Initiates Coverage On Larimar Therapeutics with Overweight Rating, Announces Price Target of $9Benzinga · May 27, 2026, 1:55 PM
Nvidia To Rally More Than 33%? Here Are 10 Top Analyst Forecasts For MondayBenzinga · May 18, 2026, 1:20 PM
Wedbush Maintains Outperform on Larimar Therapeutics, Lowers Price Target to $12Benzinga · May 18, 2026, 12:35 PM
Larimar Therapeutics shares are trading lower. The company reported Q1 EPS results.Benzinga · May 14, 2026, 5:36 PM